Management of the ataxias: towards best clinical practice

Claire Bates, Peter Baxter, Harriet Bonney, Fion Bremner, Lisa Bunn, Maria Carrillo Perez-Tome, Mark Chung, Lisa Cipolotti, Rajith de Silva, Kate Duberley, John Ealing, Anton Emmanuel, Paola Giunti, Julie Greenfield, Marios Hadjivassilliou, N.S. Harshavardhana, Kate Hayward, Christian Hendriksz, Joshua Hersheson, Rita Horvath & 12 others Joanne Hurford, Fatima Jaffer, Cherry Kilbride, Anja Lowit, Jonathan Marsden, Andrea Nemeth, M H Hilali Noordeen, Jalesh Panicker, Antonios Pantazis, Michael H Parkinson, Liz Redmond, Kai Uus

Research output: Other contribution

Abstract

This document aims to provide recommendations for healthcare professionals on the diagnosis and management of people with progressive ataxia. The progressive ataxias are rare neurological conditions, and are often poorly understood by healthcare professionals. Diagnosis has generally been a long process because of the rarity and complexity of the different ataxias1. In addition, many healthcare professionals are unsure how best to manage the conditions and there is sometimes a feeling that little can be done for these patients1,2 Although there are no disease-modifying treatments for the majority of the progressive ataxias, there are many aspects of the conditions that are treatable and it is thus important that this is recognised by the relevant healthcare professionals. The diagnosis and management of the few treatable causes is also of paramount importance. All this highlights the importance of producing these guidelines: in order to increase awareness and understanding of these conditions, and lead to their improved diagnosis and management. With new developments in genetic technologies and the discovery of more genes, diagnosis is improving and has great scope to continue to do so. In addition, research is advancing and many human trials to test medications are taking place, making us more optimistic that disease-modifying treatments will be found for the progressive ataxias.
LanguageEnglish
TypeClinical Guidelines
Number of pages88
Place of PublicationLondon
Edition3rd
Publication statusPublished - 31 Jul 2016

Fingerprint

Ataxia
Practice Guidelines
Delivery of Health Care
Genetic Association Studies
Emotions
Guidelines
Technology
Research

Keywords

  • ataxias
  • public aspects of medicine
  • clinical practice
  • guidelines

Cite this

Bates, C., Baxter, P., Bonney, H., Bremner, F., Bunn, L., Carrillo Perez-Tome, M., ... Uus, K. Management of the ataxias: towards best clinical practice.
Bates, Claire ; Baxter, Peter ; Bonney, Harriet ; Bremner, Fion ; Bunn, Lisa ; Carrillo Perez-Tome, Maria ; Chung, Mark ; Cipolotti, Lisa ; de Silva, Rajith ; Duberley, Kate ; Ealing, John ; Emmanuel, Anton ; Giunti, Paola ; Greenfield, Julie ; Hadjivassilliou, Marios ; Harshavardhana, N.S. ; Hayward, Kate ; Hendriksz, Christian ; Hersheson, Joshua ; Horvath, Rita ; Hurford, Joanne ; Jaffer, Fatima ; Kilbride, Cherry ; Lowit, Anja ; Marsden, Jonathan ; Nemeth, Andrea ; Noordeen, M H Hilali ; Panicker, Jalesh ; Pantazis, Antonios ; Parkinson, Michael H ; Redmond, Liz ; Uus, Kai. / Management of the ataxias : towards best clinical practice. 88 p.
@misc{bb670972ac0f4710ae742b9f46a5c704,
title = "Management of the ataxias: towards best clinical practice",
abstract = "This document aims to provide recommendations for healthcare professionals on the diagnosis and management of people with progressive ataxia. The progressive ataxias are rare neurological conditions, and are often poorly understood by healthcare professionals. Diagnosis has generally been a long process because of the rarity and complexity of the different ataxias1. In addition, many healthcare professionals are unsure how best to manage the conditions and there is sometimes a feeling that little can be done for these patients1,2 Although there are no disease-modifying treatments for the majority of the progressive ataxias, there are many aspects of the conditions that are treatable and it is thus important that this is recognised by the relevant healthcare professionals. The diagnosis and management of the few treatable causes is also of paramount importance. All this highlights the importance of producing these guidelines: in order to increase awareness and understanding of these conditions, and lead to their improved diagnosis and management. With new developments in genetic technologies and the discovery of more genes, diagnosis is improving and has great scope to continue to do so. In addition, research is advancing and many human trials to test medications are taking place, making us more optimistic that disease-modifying treatments will be found for the progressive ataxias.",
keywords = "ataxias, public aspects of medicine, clinical practice, guidelines",
author = "Claire Bates and Peter Baxter and Harriet Bonney and Fion Bremner and Lisa Bunn and {Carrillo Perez-Tome}, Maria and Mark Chung and Lisa Cipolotti and {de Silva}, Rajith and Kate Duberley and John Ealing and Anton Emmanuel and Paola Giunti and Julie Greenfield and Marios Hadjivassilliou and N.S. Harshavardhana and Kate Hayward and Christian Hendriksz and Joshua Hersheson and Rita Horvath and Joanne Hurford and Fatima Jaffer and Cherry Kilbride and Anja Lowit and Jonathan Marsden and Andrea Nemeth and Noordeen, {M H Hilali} and Jalesh Panicker and Antonios Pantazis and Parkinson, {Michael H} and Liz Redmond and Kai Uus",
year = "2016",
month = "7",
day = "31",
language = "English",
edition = "3rd",
type = "Other",

}

Bates, C, Baxter, P, Bonney, H, Bremner, F, Bunn, L, Carrillo Perez-Tome, M, Chung, M, Cipolotti, L, de Silva, R, Duberley, K, Ealing, J, Emmanuel, A, Giunti, P, Greenfield, J, Hadjivassilliou, M, Harshavardhana, NS, Hayward, K, Hendriksz, C, Hersheson, J, Horvath, R, Hurford, J, Jaffer, F, Kilbride, C, Lowit, A, Marsden, J, Nemeth, A, Noordeen, MHH, Panicker, J, Pantazis, A, Parkinson, MH, Redmond, L & Uus, K Management of the ataxias: towards best clinical practice.

Management of the ataxias : towards best clinical practice. / Bates, Claire; Baxter, Peter; Bonney, Harriet; Bremner, Fion; Bunn, Lisa; Carrillo Perez-Tome, Maria; Chung, Mark; Cipolotti, Lisa; de Silva, Rajith; Duberley, Kate; Ealing, John; Emmanuel, Anton; Giunti, Paola; Greenfield, Julie; Hadjivassilliou, Marios; Harshavardhana, N.S.; Hayward, Kate; Hendriksz, Christian; Hersheson, Joshua; Horvath, Rita; Hurford, Joanne; Jaffer, Fatima; Kilbride, Cherry; Lowit, Anja; Marsden, Jonathan; Nemeth, Andrea; Noordeen, M H Hilali; Panicker, Jalesh; Pantazis, Antonios; Parkinson, Michael H; Redmond, Liz; Uus, Kai.

88 p. 3rd ed. London. 2016, Clinical Guidelines.

Research output: Other contribution

TY - GEN

T1 - Management of the ataxias

T2 - towards best clinical practice

AU - Bates, Claire

AU - Baxter, Peter

AU - Bonney, Harriet

AU - Bremner, Fion

AU - Bunn, Lisa

AU - Carrillo Perez-Tome, Maria

AU - Chung, Mark

AU - Cipolotti, Lisa

AU - de Silva, Rajith

AU - Duberley, Kate

AU - Ealing, John

AU - Emmanuel, Anton

AU - Giunti, Paola

AU - Greenfield, Julie

AU - Hadjivassilliou, Marios

AU - Harshavardhana, N.S.

AU - Hayward, Kate

AU - Hendriksz, Christian

AU - Hersheson, Joshua

AU - Horvath, Rita

AU - Hurford, Joanne

AU - Jaffer, Fatima

AU - Kilbride, Cherry

AU - Lowit, Anja

AU - Marsden, Jonathan

AU - Nemeth, Andrea

AU - Noordeen, M H Hilali

AU - Panicker, Jalesh

AU - Pantazis, Antonios

AU - Parkinson, Michael H

AU - Redmond, Liz

AU - Uus, Kai

PY - 2016/7/31

Y1 - 2016/7/31

N2 - This document aims to provide recommendations for healthcare professionals on the diagnosis and management of people with progressive ataxia. The progressive ataxias are rare neurological conditions, and are often poorly understood by healthcare professionals. Diagnosis has generally been a long process because of the rarity and complexity of the different ataxias1. In addition, many healthcare professionals are unsure how best to manage the conditions and there is sometimes a feeling that little can be done for these patients1,2 Although there are no disease-modifying treatments for the majority of the progressive ataxias, there are many aspects of the conditions that are treatable and it is thus important that this is recognised by the relevant healthcare professionals. The diagnosis and management of the few treatable causes is also of paramount importance. All this highlights the importance of producing these guidelines: in order to increase awareness and understanding of these conditions, and lead to their improved diagnosis and management. With new developments in genetic technologies and the discovery of more genes, diagnosis is improving and has great scope to continue to do so. In addition, research is advancing and many human trials to test medications are taking place, making us more optimistic that disease-modifying treatments will be found for the progressive ataxias.

AB - This document aims to provide recommendations for healthcare professionals on the diagnosis and management of people with progressive ataxia. The progressive ataxias are rare neurological conditions, and are often poorly understood by healthcare professionals. Diagnosis has generally been a long process because of the rarity and complexity of the different ataxias1. In addition, many healthcare professionals are unsure how best to manage the conditions and there is sometimes a feeling that little can be done for these patients1,2 Although there are no disease-modifying treatments for the majority of the progressive ataxias, there are many aspects of the conditions that are treatable and it is thus important that this is recognised by the relevant healthcare professionals. The diagnosis and management of the few treatable causes is also of paramount importance. All this highlights the importance of producing these guidelines: in order to increase awareness and understanding of these conditions, and lead to their improved diagnosis and management. With new developments in genetic technologies and the discovery of more genes, diagnosis is improving and has great scope to continue to do so. In addition, research is advancing and many human trials to test medications are taking place, making us more optimistic that disease-modifying treatments will be found for the progressive ataxias.

KW - ataxias

KW - public aspects of medicine

KW - clinical practice

KW - guidelines

UR - https://www.ataxia.org.uk/clinical-guidelines

M3 - Other contribution

CY - London

ER -

Bates C, Baxter P, Bonney H, Bremner F, Bunn L, Carrillo Perez-Tome M et al. Management of the ataxias: towards best clinical practice. 2016. 88 p.